$14.08
-0.04-0.28%
At close: -
$14.23
0.151.07%
After Hours: Nov 7, 9:27 AM EDT
Comments
Loading...
Afya Analyst Ratings and Price Targets | NASDAQ:AFYA | Benzinga
Afya Ltd has a consensus price target of $18.79 based on the ratings of 7 analysts. The high is $24.5 issued by JP Morgan on September 8, 2025. The low is $14 issued by Citigroup on July 29, 2025. The 3 most-recent analyst ratings were released by UBS, JP Morgan, and Citigroup on September 8, 2025, September 8, 2025, and July 29, 2025, respectively. With an average price target of $19.17 between UBS, JP Morgan, and Citigroup, there's an implied 34.69% upside for Afya Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
JP Morgan
Citigroup
Morgan Stanley
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Afya
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/08/2025 | 33.52% | UBS | $19.5 → $19 | Upgrade | Neutral → Buy | |||
09/08/2025 | 72.17% | JP Morgan | $23.5 → $24.5 | Upgrade | Neutral → Overweight | |||
07/29/2025 | -1.62% | Citigroup | $16 → $14 | Upgrade | Sell → Neutral | |||
06/12/2025 | 37.03% | UBS | $17.5 → $19.5 | Maintains | Neutral | |||
03/11/2025 | 19.47% | Morgan Stanley | $19 → $17 | Downgrade | Equal-Weight → Underweight | |||
01/31/2025 | 5.41% | Citigroup | $18 → $15 | Downgrade | Neutral → Sell | |||
01/17/2025 | 44.06% | JP Morgan | $25 → $20.5 | Maintains | Neutral | |||
12/03/2024 | 12.44% | Goldman Sachs | → $16 | Initiates | → Sell | |||
08/30/2024 | 37.03% | UBS | → $19.5 | Initiates | → Neutral | |||
06/21/2024 | 33.52% | Morgan Stanley | $21 → $19 | Maintains | Equal-Weight | |||
01/22/2024 | 61.63% | Morgan Stanley | $20.5 → $23 | Downgrade | Overweight → Equal-Weight | |||
11/27/2023 | 61.63% | JP Morgan | $22 → $23 | Downgrade | Overweight → Neutral | |||
10/13/2023 | 44.06% | Morgan Stanley | $16.5 → $20.5 | Upgrade | Equal-Weight → Overweight | |||
11/22/2022 | 26.49% | Credit Suisse | $19 → $18 | Maintains | Outperform |
FAQ
What is the target price for Afya (AFYA) stock?
The latest price target for Afya (NASDAQ:AFYA) was reported by UBS on September 8, 2025. The analyst firm set a price target for $19.00 expecting AFYA to rise to within 12 months (a possible 33.52% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Afya (AFYA)?
The latest analyst rating for Afya (NASDAQ:AFYA) was provided by UBS, and Afya upgraded their buy rating.
When was the last upgrade for Afya (AFYA)?
The last upgrade for Afya Ltd happened on September 8, 2025 when UBS raised their price target to $19. UBS previously had a neutral for Afya Ltd.
When was the last downgrade for Afya (AFYA)?
The last downgrade for Afya Ltd happened on March 11, 2025 when Morgan Stanley changed their price target from $19 to $17 for Afya Ltd.
When is the next analyst rating going to be posted or updated for Afya (AFYA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Afya, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Afya was filed on September 8, 2025 so you should expect the next rating to be made available sometime around September 8, 2026.
Is the Analyst Rating Afya (AFYA) correct?
While ratings are subjective and will change, the latest Afya (AFYA) rating was a upgraded with a price target of $19.50 to $19.00. The current price Afya (AFYA) is trading at is $14.23, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
